MA Williams, JL Fleg, PA Ades, BR Chaitman, … - Circulation, 2002 - Am Heart Assoc Traditionally, components of secondary prevention programming (including
exercise; smoking cessation; management of dyslipidemia, hypertension, diabetes,
and weight; and interventions directed at depression, social isolation, ... Cited by 145 - Related articles - BL Direct - All 8 versions
AD Federman, AS Adams, D Ross-Degnan, SB … - Jama, 2001 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Cost-sharing in ... Cited by 140 - Related articles - BL Direct - All 5 versions
PH Chong, JD Seeger, C Franklin - The American journal of medicine, 2001 - Elsevier Although the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, or
statins, share a common lipid-lowering effect, there are differences within this
class of drugs. The low-density lipoprotein (LDL) cholesterol–lowering ... Cited by 116 - Related articles - BL Direct - All 4 versions
HD Aronow, GM Novaro, MS Lauer, DM Brennan … - Archives of Internal Medicine, 2003 - Am Med Assoc Methods Using data from patients at 69 centers from the United States and Canada
enrolled in the Evaluation in PTCA to Improve Long-term Outcome With Abciximab
GP IIb/IIIa Blockade (EPILOG) trial, we performed a retrospective ... Cited by 49 - Related articles - BL Direct - All 4 versions
J Avorn, JH Gurwitz, PA Rochon - Geriatric Medicine. 3rd ed. New York: Springer-Verlag, 1996 - Springer Of the four traditional components of pharmacoki- netics—absorption,
distribution, metabolism, and excre- tion—only the last three are meaningfully
affected by age. In the absence of malabsorptive syndromes, tradi- tional ... Cited by 47 - Related articles
WS Aronow - Journals of Gerontology Series A: Biological and …, 2001 - Geron Soc America Hypercholesterolemia is a risk factor for new coronary events in older men and
women. Secondary prevention trials have demonstrated in persons with coronary
artery disease (CAD) and hypercholesterolemia that statin drugs reduced in ... Cited by 31 - Related articles - BL Direct - All 3 versions
- ►adisonline.com [PDF] MMB Mungall, A Gaw, J Shepherd - Drugs &# 38; Aging, 2003 - ingentaconnect.com Abstract HMG-CoA reductase inhibitors (statins) have been established as the
domi- nant treatment for coronary heart disease (CHD). This dominance is based
on an impressive body of clinical trial evidence showing significant ... Cited by 31 - Related articles - BL Direct - All 9 versions
- ►bmj.com OH Franco, A Peeters, CWN Looman, L … - British Medical Journal, 2005 - jech.bmj.com Introduction: Statin therapy reduces the rate of coronary heart disease, but
high costs in combination with a large population eligible for treatment ask for
priority setting. Although trials agree on the size of the benefit, ... Cited by 28 - Related articles - BL Direct - All 7 versions
PJ Neumann, AB Rosen, MC Weinstein - 新英格兰医药杂志, 2005 - journal.shouxi.net Other reasons include widespread mistrust of the making of medical decisions by
organizations, rather than by individual physicians and patients, concern about
the transparency of the decision-making process, and mistrust of the ... Cited by 97 - Related articles - Cached - BL Direct - All 9 versions
